Literature DB >> 28091699

Musculoskeletal MRI findings of juvenile localized scleroderma.

Eric P Eutsler1,2, Daniel B Horton3,4, Monica Epelman5, Terri Finkel6, Lauren W Averill7.   

Abstract

BACKGROUND: Juvenile localized scleroderma comprises a group of autoimmune conditions often characterized clinically by an area of skin hardening. In addition to superficial changes in the skin and subcutaneous tissues, juvenile localized scleroderma may involve the deep soft tissues, bones and joints, possibly resulting in functional impairment and pain in addition to cosmetic changes.
OBJECTIVE: There is literature documenting the spectrum of findings for deep involvement of localized scleroderma (fascia, muscles, tendons, bones and joints) in adults, but there is limited literature for the condition in children. We aimed to document the spectrum of musculoskeletal magnetic resonance imaging (MRI) findings of both superficial and deep juvenile localized scleroderma involvement in children and to evaluate the utility of various MRI sequences for detecting those findings.
MATERIALS AND METHODS: Two radiologists retrospectively evaluated 20 MRI studies of the extremities in 14 children with juvenile localized scleroderma. Each imaging sequence was also given a subjective score of 0 (not useful), 1 (somewhat useful) or 2 (most useful for detecting the findings).
RESULTS: Deep tissue involvement was detected in 65% of the imaged extremities. Fascial thickening and enhancement were seen in 50% of imaged extremities. Axial T1, axial T1 fat-suppressed (FS) contrast-enhanced and axial fluid-sensitive sequences were rated most useful.
CONCLUSION: Fascial thickening and enhancement were the most commonly encountered deep tissue findings in extremity MRIs of children with juvenile localized scleroderma. Because abnormalities of the skin, subcutaneous tissues and fascia tend to run longitudinally in an affected limb, axial T1, axial fluid-sensitive and axial T1-FS contrast-enhanced sequences should be included in the imaging protocol.

Entities:  

Keywords:  Children; Juvenile localized scleroderma; Magnetic resonance imaging; Morphea; Musculoskeletal; Scleroderma

Mesh:

Year:  2017        PMID: 28091699     DOI: 10.1007/s00247-016-3765-x

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  16 in total

1.  Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.

Authors:  F Zulian; B H Athreya; R Laxer; A M Nelson; S K Feitosa de Oliveira; M G Punaro; R Cuttica; G C Higgins; L W A Van Suijlekom-Smit; T L Moore; C Lindsley; J Garcia-Consuegra; M O Esteves Hilário; L Lepore; C A Silva; C Machado; S M Garay; Y Uziel; G Martini; I Foeldvari; A Peserico; P Woo; J Harper
Journal:  Rheumatology (Oxford)       Date:  2005-12-20       Impact factor: 7.580

2.  Localized scleroderma in childhood is not just a skin disease.

Authors:  Francesco Zulian; Cristina Vallongo; Patricia Woo; Ricardo Russo; Nicolino Ruperto; John Harper; Graciela Espada; Fabrizia Corona; Masha Mukamel; Richard Vesely; Elzbieta Musiej-Nowakowska; Jeff Chaitow; Joan Ros; Maria T Apaz; Valeria Gerloni; Henryka Mazur-Zielinska; Susan Nielsen; Susanne Ullman; Gerd Horneff; Carine Wouters; Giorgia Martini; Rolando Cimaz; Ronald Laxer; Balu H Athreya
Journal:  Arthritis Rheum       Date:  2005-09

3.  Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.

Authors:  Suzanne C Li; Kathryn S Torok; Elena Pope; Fatma Dedeoglu; Sandy Hong; Heidi T Jacobe; C Egla Rabinovich; Ronald M Laxer; Gloria C Higgins; Polly J Ferguson; Andrew Lasky; Kevin Baszis; Mara Becker; Sarah Campillo; Victoria Cartwright; Michael Cidon; Christi J Inman; Rita Jerath; Kathleen M O'Neil; Sheetal Vora; Andrew Zeft; Carol A Wallace; Norman T Ilowite; Robert C Fuhlbrigge
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-08       Impact factor: 4.794

4.  High frequency ultrasound can detect improvement of lesions in juvenile localized scleroderma.

Authors:  Francesco Porta; Olga Kaloudi; Alice Garzitto; Francesca Prignano; Francesca Nacci; Fernanda Falcini; Marco Matucci Cerinic
Journal:  Mod Rheumatol       Date:  2013-10-18       Impact factor: 3.023

5.  Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland.

Authors:  Ariane L Herrick; Holly Ennis; Monica Bhushan; Alan J Silman; Eileen M Baildam
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

6.  Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial.

Authors:  Francesco Zulian; Giorgia Martini; Cristina Vallongo; Fabio Vittadello; Fernanda Falcini; Annalisa Patrizi; Maria Alessio; Francesco La Torre; Rosa A Podda; Valeria Gerloni; Mario Cutrone; Anna Belloni-Fortina; Mauro Paradisi; Silvana Martino; Giorgio Perilongo
Journal:  Arthritis Rheum       Date:  2011-07

7.  Response evaluation of musculoskeletal involvement in patients with deep morphea treated with methotrexate and prednisolone: a combined MRI and clinical approach.

Authors:  Stefan Schanz; Jörg Henes; Anja Ulmer; Ina Kötter; Gerhard Fierlbeck; Claus Detlef Claussen; Marius Horger
Journal:  AJR Am J Roentgenol       Date:  2013-04       Impact factor: 3.959

8.  Sonographic evaluation of pediatric localized scleroderma: preliminary disease assessment measures.

Authors:  Suzanne C Li; Melissa S Liebling; Faridali G Ramji; Sven Opitz; Arun Mohanta; Tatiana Kornyat; Shuzhen Zhang; Molly Dempsey-Robertson; Carsten Hamer; Stephanie Edgerton; Jose Jarrin; Mike Malone; Andrea S Doria
Journal:  Pediatr Rheumatol Online J       Date:  2010-04-27       Impact factor: 3.054

9.  Localized scleroderma: imaging features.

Authors:  P Liu; Y Uziel; S Chuang; E Silverman; B Krafchik; R Laxer
Journal:  Pediatr Radiol       Date:  1994

Review 10.  Scleroderma in children: an update.

Authors:  Francesco Zulian; Giorgio Cuffaro; Francesca Sperotto
Journal:  Curr Opin Rheumatol       Date:  2013-09       Impact factor: 5.006

View more
  7 in total

1.  A Cross-sectional Comparison of Magnetic Resonance Imaging Findings and Clinical Assessment in Patients With Morphea.

Authors:  Laila F Abbas; Jack C O'Brien; Shauna Goldman; Parham Pezeshk; Majid Chalian; Avneesh Chhabra; Heidi T Jacobe
Journal:  JAMA Dermatol       Date:  2020-05-01       Impact factor: 10.282

2.  Keeping up with the progress in the diagnosis and management of pediatric rheumatic diseases.

Authors:  Hong-Mei Song
Journal:  World J Pediatr       Date:  2020-02       Impact factor: 2.764

Review 3.  Why, how, and when to use color Doppler ultrasound for improving precision in the diagnosis, assessment of severity and activity in morphea.

Authors:  Ximena Wortsman
Journal:  J Scleroderma Relat Disord       Date:  2018-09-24

Review 4.  Progressive Hemifacial Atrophy and Linear Scleroderma En Coup de Sabre: A Spectrum of the Same Disease?

Authors:  Irina Khamaganova
Journal:  Front Med (Lausanne)       Date:  2018-01-31

Review 5.  Autoantibodies in Morphea: An Update.

Authors:  Sangita Khatri; Kathryn S Torok; Emily Mirizio; Christopher Liu; Kira Astakhova
Journal:  Front Immunol       Date:  2019-07-09       Impact factor: 7.561

Review 6.  Morphea: progress to date and the road ahead.

Authors:  Laila Abbas; Adrienne Joseph; Elaine Kunzler; Heidi T Jacobe
Journal:  Ann Transl Med       Date:  2021-03

7.  Magnetic Resonance Imaging Evaluation in Patients with Linear Morphea Treated with Methotrexate and High-Dose Corticosteroid.

Authors:  Mohammad Shahidi-Dadras; Fahimeh Abdollahimajd; Razieh Jahangard; Ali Javinani; Amir Ashraf-Ganjouei; Parviz Toossi
Journal:  Dermatol Res Pract       Date:  2018-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.